Group Leader - Regenerative Medicine
Ref.: 23-259_R_AR
IDIBELL is looking for an ambitious and highly motivated scientist with an outstanding track-record of scientific accomplishments to apply for an independent tenure-track Group Leader research position in the Regenerative Medicine Program
About the program
The Regenerative Medicine Program integrates fundamental and translational research on the use of cells and tissues to treat degenerative diseases. The Program is currently composed by 8 independent research groups whose activities span broad areas of science, including stem cell biology, developmental biology, regeneration and aging, development of advanced therapies, and molecular mechanisms of disease. Researchers within the Regenerative Medicine Program of IDIBELL employ experimental systems that range from zebrafish and mice to human pluripotent stem cells and organoids. The Program also hosts the Barcelona Stem Cell Bank, node of the Carlos III Institute of Health's Spanish Cell Bank, which generates, registers, and banks human iPS cell lines.
The Regenerative Medicine Program is a key part of the Program for the Clinical Translation of Regenerative Medicine in Catalonia (P-CMR[C]), a transversal action in the Catalan environment that brings together the relevant stakeholders for advancing the clinical translation of strategies of regenerative medicine based on the use of pluripotent stem cells.
Group leaders at IDIBELL’s Regenerative Medicine Program benefit from a highly collaborative, approachable and international English-speaking environment.
We provide fully equipped laboratory space for up to 6-8 people, priority access to on site facilities and access to additional special equipment if required.
Besides the laboratories and stem cell culture facilities, IDIBELL hosts a complete Core Facility Unit, offering support in the Molecular Interactions, Spatial Genomics & Transcriptomics, Flow Cytometry, Bioimaging, and Histology Platforms and services in Animal Facility (including aquatic animals), Biobank, Bioinformatics, Biostatistics, and Clinical Trials.
About the role
The successful candidate will lead an independent research group with no teaching obligations and will be appointed for an initial 4-year tenure-track period, starting during 2025.
Successful candidate will benefit from:
-
A vibrant, international, and collaborative environment
-
A flexible start up package to set up the lab, the initial team (up to three positions) and lab expenses
-
Access to state-of-the-art research facilities
-
Training in collaboration with other institutions
-
Tailored support in raising competitive funds
Job requirements
Professional experience
Education and training
Technical & soft skills
Languages
What do we offer
-
No. of positions: 1
-
Estimated start date: 2025
-
Contract duration: 4 years
-
Estimated annual gross salary: It is commensurate with qualifications and consistent with our pay ranges.
-
You will be part of a multicultural team. We have a fun loving and friendly international work environment.
-
Flexible working schedule - We know you have a life outside of work and we will work with you to make sure it's kept that way.
-
Possibility to work some days in remote - Teleworking
-
26 working days of holiday per year
-
System of accumulated hours for employees, from 88 to 104 hours depending on the year (11 to 13 working days), to attend to personal matters.
-
Paid leave package
-
Benefits of constant training are offered
-
We offer and promote diverse and inclusive conditions. Applicants are made free from any discrimination. Specifically IDIBELL works to improve gender equality in all areas with the aim of achieving gender balance, but maintaining the most scrupulous respect to any choice at the level of gender identity. Please express yourself freely, safely and non-binarily, if that's the case.
Selection process
Informal inquiries are welcome and should be addressed to the Coordinator of the Regenerative Medicine Program, Prof. Angel Raya at araya@idibell.cat
-
Interview: Candidates best positioned and pre-selected by an international scientific committee will be invited for an onsite interview by mid-February 2024 at IDIBELL. The panel will consist of the internal selection committee and members of the international scientific advisory board.
-
Formal offer letter: Once identified, an official offer letter will be issued to the successful candidate indicating start date, salary, working conditions, and any additional relevant details.
Deadline: Please submit your application by 31/12/2023
Data protection notice
In compliance with the obligations established in the General Regulation of Data Protection (RGPD), which is the Regulation (EU) 2016/679 of the Parliament and of the Council, of April 27, 2016, and the Organic Law 3/2018, of December 5, Protection of Personal Data and guarantee of digital rights, it is reported that the Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), CIF G58863317, with address Av. Granvia de l'Hospitalet, 199-203, 08908, L'Hospitalet de Llobregat, will process your personal data, as the controller, to apply for the position, maintain communication concerning the status of the candidature, to access the delivered CV; to compare that your data is in accordance with the offers announced by IDIBELL and to verify, where appropriate, that the information provided is accurate.
You can find more information in our Privacy Policy at https://idibell.cat/en/privacy-policy-2/, request more information about the data processing carried out and exercise your rights of access, rectification, deletion, opposition, portability, limitation of processing by sending a request at email: dataprotection@idibell.cat. If you consider that you have not obtained satisfaction in exercising your rights, you may submit a claim to Catalan Data Protection Authority.
Our institute
IDIBELL is a research center that integrates the biomedical research of the Bellvitge University Hospital (HUB), the Catalan Institute of Oncology (ICO), and the University of Barcelona in the Bellvitge Campus (UB), and the Viladecans Hospital (HV). The research focuses of IDIBELL are cancer, neuroscience, translational medicine and regenerative medicine. Research, innovation and society are the pivots on which researchers work every day in order to improve the quality of life of citizens.
Observations
The 'HR Excellence in Research' award represents IDIBELL’s commitment to the implementation of Human Resources policies, which oversee the attracting and development of talent in an open, transparent, and based on personal merit, in alignment with the principles of the European Charter for Researchers and the Code of Conduct for the Recruitment Researchers (Charter and Code).
IDIBELL is committed to the principles of the Code of Conduct for the Recruitment of Researchers of the European Commission and the implementation of open, transparent and merit-based recruitment (OTMR).
